Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
PUT
Coupang
CPNG
$29.5B
| $3.24M | ﹤0.01% |
+116,300
| New | +$4.02M |
|
2102
Vericel Corp
VCEL
$2.36B
| $3.24M | ﹤0.01% |
66,355
-31,535
| -32% | -$1.63M |
|
2103
Cirrus Logic
CRUS
$6.42B
| $3.23M | ﹤0.01% |
39,274
+12,575
| +47% | +$1.05M |
|
2104
PUT
iShares Biotechnology ETF
IBB
$9.18B
| $3.23M | ﹤0.01% |
+20,000
| New | +$3.37M |
|
2105
National Vision
EYE
$1.8B
| $3.23M | ﹤0.01% |
56,934
+30,784
| +118% | +$1.7M |
|
2106
Sprouts Farmers Market
SFM
$8.28B
| $3.23M | ﹤0.01% |
139,375
-307
| -0.2% | -$7.47K |
|
2107
CALL
Trip.com Group
TCOM
$29.8B
| $3.23M | ﹤0.01% |
105,000
| – | – |
|
|
GWB
2108
DELISTED
Great Western Bancorp, Inc.
GWB
| $3.23M | ﹤0.01% |
98,558
+26,062
| +36% | +$803K |
|
2109
Imperial Oil
IMO
$61.1B
| $3.22M | ﹤0.01% |
102,036
-30,498
| -23% | -$843K |
|
|
ESGR
2110
DELISTED
Enstar Group
ESGR
| $3.22M | ﹤0.01% |
13,708
-786
| -5% | -$192K |
|
2111
iShares MSCI Indonesia ETF
EIDO
$484M
| $3.21M | ﹤0.01% |
147,808
+22,412
| +18% | +$465K |
|
2112
iShares Russell 3000 ETF
IWV
$19.9B
| $3.2M | ﹤0.01% |
12,568
-1,276
| -9% | -$334K |
|
2113
RadNet
RDNT
$5.25B
| $3.2M | ﹤0.01% |
109,100
-26
| -0% | -$834 |
|
|
K
2114
PUT
DELISTED
Kellanova
K
| $3.2M | ﹤0.01% |
53,250
| – | – |
|
2115
Travel + Leisure Co
TNL
$4.72B
| $3.19M | ﹤0.01% |
58,582
-33,501
| -36% | -$1.83M |
|
2116
CRISPR Therapeutics
CRSP
$4.88B
| $3.19M | ﹤0.01% |
28,513
-4,648
| -14% | -$584K |
|
2117
Grand Canyon Education
LOPE
$3.93B
| $3.19M | ﹤0.01% |
36,281
-44,405
| -55% | -$3.95M |
|
2118
CALL
American Tower
AMT
$80.6B
| $3.19M | ﹤0.01% |
12,000
| – | – |
|
2119
CALL
Dollar General
DG
$28.2B
| $3.18M | ﹤0.01% |
15,000
| – | – |
|
2120
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $3.18M | ﹤0.01% |
33,789
-46,458
| -58% | -$4.27M |
|
|
VISN
2121
CALL
Vistance Networks Inc
VISN
$2.72B
| $3.17M | ﹤0.01% |
+233,300
| New | +$4.01M |
|
|
CANO
2122
PUT
DELISTED
Cano Health, Inc.
CANO
| $3.17M | ﹤0.01% |
+2,500
| New | +$3.03M |
|
2123
Allegiant Air
ALGT
$2.78B
| $3.17M | ﹤0.01% |
16,207
-2,828
| -15% | -$543K |
|
2124
Bank OZK
OZK
$5.65B
| $3.17M | ﹤0.01% |
73,725
-115,658
| -61% | -$4.82M |
|
|
AMED
2125
DELISTED
Amedisys
AMED
| $3.17M | ﹤0.01% |
21,233
-16,848
| -44% | -$3.5M |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.